Boston, Massachusetts, United States
I’m passionate about entrepreneurship, innovation, and community building in the life sciences. As PhD #92 from the Church Lab, I’ve always been fascinated by how cutting-edge research can be transformed into real-world impact. During my PhD, where I studied the genetic basis of controlled cell migration, I also co-founded Nucleate — a global nonprofit dedicated to empowering the next generation of biotech leaders. Now, as Executive Director, I work full-time to grow our community, connect innovators with the right resources, and support our brilliant and diverse Leadership team. I’m particularly interested in: 🔬 Therapeutics — transforming breakthrough science into real impact for patients living with debilitating diseases 🤖 Automation & AI — reshaping biotech, scientific discovery, and the modern workforce 📚 Lifelong learning — whether it’s a research paper, poetry, or a sci-fi novel, I’m always reading Let’s connect if you’re interested in biotech startups, venture funding, or the future of life sciences! 🚀
Nucleate Bio is an international non-profit organization that empowers the next generation of biotech leaders through open access programming and educational resources. Oliver served as the founding EVP of Operations and then subsequently as Co-President of Nucleate (until June 2023), as well as Treasurer on Nucleate's Board of Directors. He is now working in a full-time capacity as Nucleate's Executive Director.
Co-lead on SomaCode project. At SomaCode, we are using our proprietary "genetic positioning system (GPS)" technology to discover genes that control cell migration to tissues of interests. SomaCode is focused on developing cell therapy assets with enhanced migration profiles that increase their on-target and decrease off-target biological effects in-vivo. Advisor: Dr. George Church Harvard Department of Genetics Biological and Biomedical Sciences (BBS) Program
Investing in seed-stage founders building great life sciences companies. https://www.petri.bio/